It has been a busy year for Research and Policy, with the publication of five key new clinical guidelines. These are:

• Pre-pregnancy Counselling (C-Obs 3a)
• Contraception (C-Gyn 3)
• Screening and Diagnosis of Fetal Structural Anomalies and Chromosome Conditions (C-Obs 35)
• Substance Use in Pregnancy (C-Obs 53)
• Early Pregnancy Screening and Prevention of Preterm Preeclampsia and Related Complications (C-Obs 61)

Research and Policy and the Women’s Health Committee would like to thank all Guideline Development Group Chairs and members for their valued work and contributions. All new guidelines can be accessed on the College website.

Looking ahead to 2025

Research and Policy has an exciting program of work planned for 2025, including but not limited to:

• Development of a new evidence-based RANZCOG guideline on Menopause (including genitourinary syndrome and premature ovarian syndrome).
• Development of a new and Robotic Surgery in Gynaecology (including urogynaecology and gynae-oncology).
• Updates to RANZCOG’s portfolio of Patient Information Pamphlets.

Digital Access and Improvements

In keeping with the theme of this issue, Research and Policy acknowledges that timely and easy access to clinical guidance via digital platforms is important. Currently, RANZCOG’s evidence-based clinical guidance statements are accessible online, and work is ongoing to improve search functions and layout to ensure you can access information when its needed.

Get involved in 2025!

Opportunities to participate in guideline development and provide feedback on draft work are advertised in Connect – please keep an eye out throughout 2025. RANZCOG trainees with a keen interest in evidence-based medicine are also encouraged to undertake the new Evidence Based Medicine Special Interest Module. This will be available from February 2025. Please contact Professor Cindy Farquhar via [email protected] for further information.

Thank you to College members for your support and engagement with Research and Policy in 2024.

Contact us

To connect with RANZCOG Research and Policy, or to provide feedback about guidelines or Patient Information Pamphlets, please contact: [email protected]